LCM
RXST icon

Legato Capital Management’s RxSight RXST Stock Holding History

Legato Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,871
Closed -$883K – 612
2024
Q3 		$883K Sell
17,871
-11,929
-40% -$611K 0.11% 333
2024
Q2 		$1.79M Buy
29,800
+9,486
+47% +$542K 0.24% 146
2024
Q1 		$1.05M Sell
20,314
-6
-0% -$295 0.13% 263
2023
Q4 		$819K Buy
20,320
+7,395
+57% +$217K 0.11% 310
2023
Q3 		$360K Buy
+12,925
New +$385K 0.05% 464

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Legato Capital Management's RXST Position: Q4 2024 in Review

Legato Capital Management sold out of RxSight (RXST) in Q4 2024, closing a stake of 17,871 shares — an estimated $883K sold.

Legato Capital Management first reported a position in RXST in Q3 2023 and held it in 5 quarters. The position peaked at $1.79M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Legato Capital Management reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Legato Capital Management sold 17,871 RxSight shares in Q4 2024, an estimated $883K.
  • Legato Capital Management first reported a position in RxSight in Q3 2023 and held it in 5 quarters.
  • Legato Capital Management's RxSight position peaked at $1.79M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Legato Capital Management's 13F filing for Q4 2024, filed 29 Jan 2025.